Fluorine in PDB 8eiq: The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg
Enzymatic activity of The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg
All present enzymatic activity of The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg:
5.6.1.6;
Other elements in 8eiq:
The structure of The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg
(pdb code 8eiq). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg, PDB code: 8eiq:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 8eiq
Go back to
Fluorine Binding Sites List in 8eiq
Fluorine binding site 1 out
of 6 in the The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1508
b:62.5
occ:1.00
|
F
|
A:WJX1508
|
0.0
|
62.5
|
1.0
|
C17
|
A:WJX1508
|
1.3
|
60.3
|
1.0
|
F1
|
A:WJX1508
|
2.1
|
62.1
|
1.0
|
F2
|
A:WJX1508
|
2.1
|
59.4
|
1.0
|
C14
|
A:WJX1508
|
2.4
|
57.9
|
1.0
|
C16
|
A:WJX1508
|
2.8
|
50.3
|
1.0
|
C15
|
A:WJX1508
|
3.0
|
51.8
|
1.0
|
CD1
|
A:ILE132
|
3.5
|
56.6
|
1.0
|
CG1
|
A:ILE132
|
3.6
|
57.9
|
1.0
|
C13
|
A:WJX1508
|
3.7
|
56.2
|
1.0
|
CG2
|
A:ILE132
|
4.1
|
52.2
|
1.0
|
CB
|
A:ILE132
|
4.5
|
51.7
|
1.0
|
O
|
A:WJX1508
|
4.8
|
54.7
|
1.0
|
CG1
|
A:VAL1108
|
4.9
|
41.7
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 8eiq
Go back to
Fluorine Binding Sites List in 8eiq
Fluorine binding site 2 out
of 6 in the The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1508
b:62.1
occ:1.00
|
F1
|
A:WJX1508
|
0.0
|
62.1
|
1.0
|
C17
|
A:WJX1508
|
1.3
|
60.3
|
1.0
|
F
|
A:WJX1508
|
2.1
|
62.5
|
1.0
|
F2
|
A:WJX1508
|
2.1
|
59.4
|
1.0
|
C14
|
A:WJX1508
|
2.4
|
57.9
|
1.0
|
C13
|
A:WJX1508
|
2.8
|
56.2
|
1.0
|
C16
|
A:WJX1508
|
3.0
|
50.3
|
1.0
|
C15
|
A:WJX1508
|
3.7
|
51.8
|
1.0
|
O
|
A:WJX1508
|
4.1
|
54.7
|
1.0
|
CE
|
A:MET1105
|
4.5
|
50.4
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 8eiq
Go back to
Fluorine Binding Sites List in 8eiq
Fluorine binding site 3 out
of 6 in the The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1508
b:59.4
occ:1.00
|
F2
|
A:WJX1508
|
0.0
|
59.4
|
1.0
|
C17
|
A:WJX1508
|
1.3
|
60.3
|
1.0
|
F
|
A:WJX1508
|
2.1
|
62.5
|
1.0
|
F1
|
A:WJX1508
|
2.1
|
62.1
|
1.0
|
C14
|
A:WJX1508
|
2.4
|
57.9
|
1.0
|
C15
|
A:WJX1508
|
2.8
|
51.8
|
1.0
|
C13
|
A:WJX1508
|
2.9
|
56.2
|
1.0
|
C16
|
A:WJX1508
|
3.7
|
50.3
|
1.0
|
CE
|
A:MET1105
|
3.9
|
50.4
|
1.0
|
O
|
A:WJX1508
|
4.3
|
54.7
|
1.0
|
CG
|
A:MET1105
|
4.3
|
51.3
|
1.0
|
CB
|
A:MET1105
|
4.6
|
39.4
|
1.0
|
CG2
|
A:ILE132
|
4.7
|
52.2
|
1.0
|
SD
|
A:MET1105
|
4.8
|
73.4
|
1.0
|
CG1
|
A:ILE132
|
4.8
|
57.9
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 8eiq
Go back to
Fluorine Binding Sites List in 8eiq
Fluorine binding site 4 out
of 6 in the The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1509
b:66.3
occ:1.00
|
F
|
A:CV61509
|
0.0
|
66.3
|
1.0
|
C9
|
A:CV61509
|
1.4
|
53.3
|
1.0
|
C8
|
A:CV61509
|
2.3
|
54.0
|
1.0
|
C10
|
A:CV61509
|
2.3
|
51.5
|
1.0
|
N1
|
A:CV61509
|
2.7
|
53.4
|
1.0
|
CG1
|
A:ILE70
|
3.5
|
56.9
|
1.0
|
C11
|
A:CV61509
|
3.6
|
60.9
|
1.0
|
C7
|
A:CV61509
|
3.6
|
56.2
|
1.0
|
CZ3
|
A:TRP361
|
3.6
|
42.4
|
1.0
|
CD1
|
A:ILE70
|
3.7
|
62.0
|
1.0
|
C15
|
A:CV61509
|
4.0
|
54.2
|
1.0
|
C6
|
A:CV61509
|
4.1
|
61.0
|
1.0
|
CH2
|
A:TRP361
|
4.2
|
47.4
|
1.0
|
C24
|
A:CV61509
|
4.2
|
53.0
|
1.0
|
CD2
|
A:LEU365
|
4.3
|
47.6
|
1.0
|
C19
|
A:CV61509
|
4.5
|
51.8
|
1.0
|
C23
|
A:CV61509
|
4.6
|
49.8
|
1.0
|
C14
|
A:CV61509
|
4.7
|
62.8
|
1.0
|
CE3
|
A:TRP361
|
4.7
|
40.7
|
1.0
|
C5
|
A:D121506
|
4.7
|
61.4
|
1.0
|
C16
|
A:CV61509
|
4.8
|
46.3
|
1.0
|
N
|
A:CV61509
|
4.9
|
61.7
|
1.0
|
C6
|
A:D121506
|
4.9
|
62.2
|
1.0
|
O3
|
A:CV61509
|
4.9
|
61.0
|
1.0
|
CB
|
A:ILE70
|
5.0
|
52.3
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 8eiq
Go back to
Fluorine Binding Sites List in 8eiq
Fluorine binding site 5 out
of 6 in the The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1509
b:62.5
occ:1.00
|
F1
|
A:CV61509
|
0.0
|
62.5
|
1.0
|
C25
|
A:CV61509
|
1.3
|
55.6
|
1.0
|
F2
|
A:CV61509
|
2.1
|
57.6
|
1.0
|
O5
|
A:CV61509
|
2.2
|
57.8
|
1.0
|
O4
|
A:CV61509
|
2.2
|
51.3
|
1.0
|
C22
|
A:CV61509
|
3.2
|
50.3
|
1.0
|
C21
|
A:CV61509
|
3.2
|
51.6
|
1.0
|
CD2
|
A:TRP361
|
3.4
|
43.7
|
1.0
|
CE2
|
A:TRP361
|
3.5
|
48.0
|
1.0
|
CE3
|
A:TRP361
|
3.5
|
40.7
|
1.0
|
CB
|
A:ALA198
|
3.7
|
42.6
|
1.0
|
CZ3
|
A:TRP361
|
3.8
|
42.4
|
1.0
|
CZ2
|
A:TRP361
|
3.8
|
46.9
|
1.0
|
CG
|
A:TRP361
|
3.9
|
40.0
|
1.0
|
CH2
|
A:TRP361
|
4.0
|
47.4
|
1.0
|
OG
|
A:SER364
|
4.0
|
53.1
|
1.0
|
CB
|
A:SER364
|
4.0
|
44.3
|
1.0
|
NE1
|
A:TRP361
|
4.1
|
43.5
|
1.0
|
CG2
|
A:THR360
|
4.1
|
31.7
|
1.0
|
CA
|
A:TRP361
|
4.2
|
31.1
|
1.0
|
CD1
|
A:TRP361
|
4.2
|
45.1
|
1.0
|
C23
|
A:CV61509
|
4.4
|
49.8
|
1.0
|
C20
|
A:CV61509
|
4.4
|
51.5
|
1.0
|
O
|
A:THR360
|
4.5
|
48.5
|
1.0
|
N
|
A:TRP361
|
4.5
|
33.2
|
1.0
|
C
|
A:THR360
|
4.6
|
37.9
|
1.0
|
CB
|
A:TRP361
|
4.6
|
33.6
|
1.0
|
CA
|
A:ALA198
|
4.7
|
39.0
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 8eiq
Go back to
Fluorine Binding Sites List in 8eiq
Fluorine binding site 6 out
of 6 in the The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of The Complex of Phosphorylated Human Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) with Trikafta [Elexacaftor (Vx-445), Tezacaftor (Vx-661), Ivacaftor (Vx-770)] and Atp/Mg within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1509
b:57.6
occ:1.00
|
F2
|
A:CV61509
|
0.0
|
57.6
|
1.0
|
C25
|
A:CV61509
|
1.3
|
55.6
|
1.0
|
F1
|
A:CV61509
|
2.1
|
62.5
|
1.0
|
O5
|
A:CV61509
|
2.2
|
57.8
|
1.0
|
O4
|
A:CV61509
|
2.2
|
51.3
|
1.0
|
C21
|
A:CV61509
|
3.0
|
51.6
|
1.0
|
C22
|
A:CV61509
|
3.0
|
50.3
|
1.0
|
OG
|
A:SER364
|
3.3
|
53.1
|
1.0
|
CD1
|
A:LEU195
|
3.7
|
53.6
|
1.0
|
CB
|
A:SER364
|
3.8
|
44.3
|
1.0
|
CG2
|
A:THR360
|
3.9
|
31.7
|
1.0
|
CG
|
A:LEU195
|
3.9
|
45.3
|
1.0
|
CB
|
A:ALA198
|
4.0
|
42.6
|
1.0
|
CA
|
A:LEU195
|
4.2
|
53.0
|
1.0
|
N
|
A:LEU195
|
4.3
|
48.0
|
1.0
|
C20
|
A:CV61509
|
4.3
|
51.5
|
1.0
|
C23
|
A:CV61509
|
4.4
|
49.8
|
1.0
|
C
|
A:GLY194
|
4.4
|
52.8
|
1.0
|
O
|
A:GLY194
|
4.4
|
62.1
|
1.0
|
CB
|
A:LEU195
|
4.7
|
43.8
|
1.0
|
O
|
A:THR360
|
5.0
|
48.5
|
1.0
|
|
Reference:
K.Fiedorczuk,
J.Chen.
Molecular Structures Reveal Synergistic Rescue of Delta 508 Cftr By Trikafta Modulators. Science V. 378 284 2022.
ISSN: ESSN 1095-9203
PubMed: 36264792
DOI: 10.1126/SCIENCE.ADE2216
Page generated: Fri Aug 2 18:11:26 2024
|